Skip to main content

Table 8 GMP process validation

From: Bone marrow-derived cells for cardiovascular cell therapy: an optimized GMP method based on low-density gradient improves cell purity and function

Parameter

Specification

Results – Lot Number:

002.12

004.12

005.12

Visual control: appearance

Limpid; absence of micro aggregates, colorless to slightly hematic

Limpid, absence of micro aggregates, colorless

Limpid, absence of micro aggregates, colorless

Limpid, absence of micro aggregates, colorless

Integrity of primary container

Intact

Intact

Intact

Intact

Sterility

No growth

No growth

No growth

No growth

Bacterial endotoxins (EU/ml)

< 5.00

< 5.00

< 5.00

< 5.00

Cell concentration (WBC/ml)

FIO

1.20 × 106

2.40 × 106

1.25 × 106

Lymphocytes (%)

≥ 30

71

57

61

Monocytes (%)

≥ 8

14

16

14

Granulocytes (%)

≤ 55

15

27

25

Platelet concentration (PLT/ml)

FIO

6.30 × 106

1.50 × 107

7.50 × 106

PLT/WBC

≤ 10

5

6

6

Hematocrit (%)

≤ 3

0.1

0.1

0.05

CD45+/CD34+ (%)

FIO

2.94

8.41

8.95

CD45+/CD133+ (%)

FIO

1.42

3.8

4.25

Cell viability (%)

≥ 70

74

84

99

CFC (colonies/106 cells)

FIO

2 450

9 850

11 550

CFU-F (colonies/106 cells)

FIO

44

55

36

Invasion (invasion index)

FIO

35

59

47

  1. EU: Endotoxin Units; WBC: White Blood Cells; PLT: Platelets; CFC: Colony Forming Cells; CFU-F: Colony Forming Units-Fibroblasts; FIO: For information only.